777 replies to this topic

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Drops by -14.58%
OTC Outlook - 1 hour ago

BioTime, Inc. (NYSEMKT:BTX) has lost 14.58% during the past week and dropped 15.25% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 11.37%.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Drops by -14.58%
OTC Outlook - 5 hours ago

BioTime, Inc. (NYSEMKT:BTX) has lost 14.58% during the past week and dropped 15.25% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 11.37%.

Insider Selling: BioTime insider Sells $383000.00 in Stock (BTX) - MidSouth Newz
BioTime Director Purchases $191500.00 in Stock (BTX) - WKRB News

View the full article

[ImmInst]

Form 8-K BIOTIME INC For: Nov 18
StreetInsider.com - 3 hours ago

(BUSINESS WIRE)--November 18, 2015--BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the Company's Board of Directors has appointed ...

BioTime, Inc. Announces the Appointment of Life Sciences Industry Veteran ... - PharmiWeb.com (press release)

View the full article

[ImmInst]

New finance chief at BioTime
Seeking Alpha - 7 hours ago

"This loophole in the Dual Listing Law [TASE Isreali Stock Exchange] has in fact existed for years, but was first exploited only last month when BioTime announced, a day before its official accession to the indices, that the ETFs and tracking funds ...

View the full article

[ImmInst]

New finance chief at BioTime
Seeking Alpha - 11 hours ago

"This loophole in the Dual Listing Law [TASE Isreali Stock Exchange] has in fact existed for years, but was first exploited only last month when BioTime announced, a day before its official accession to the indices, that the ETFs and tracking funds ...

CFO Moves: OpenTable, BioTime - Wall Street Journal (blog)

View the full article

[ImmInst]

What's Ahead for BioTime, Inc. After Today's Huge Increase?
FinancialMagazin.com - 7 hours ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock increased 6.77% or $0.22 during the last trading session, hitting $3.47.

View the full article

[ImmInst]

Time to Buy BioTime, Inc. After Today's Huge Increase?
FinancialMagazin.com - 1 hour ago

The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock increased 5.97% or $0.21 during the last trading session, hitting $3.73.

View the full article

[ImmInst]

BioTime, Inc. to Present at Oppenheimer Annual Healthcare Conference
Business Wire (press release) - 2 hours ago

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that Adi Mohanty, Co-Chief Executive Officer, is scheduled ...

View the full article

[ImmInst]

BioTime, Inc. (NYSEMKT:BTX)'s Company Shares Decreased 8.07% After Low Volatility
FinancialMagazin.com - 2 hours ago

The shares of BioTime, Inc. (NYSEMKT:BTX) decreased by 8.07% in the last 20 days but rose 0.28% in the past 5 trading sessions.

View the full article

[ImmInst]

BioTime, Inc. (NYSEMKT:BTX) November Short Interest Update
Insider Trading Report - 5 minutes ago

The short interest in BioTime, Inc. (NYSEMKT:BTX) has declined from 7,824,168 on November 13,2015 to 7,730,830 on November 30,2015.

View the full article

[ImmInst]

BioTime, Inc. Announces Record Date, Distribution Ratio, and Distribution Date ...
Equities.com - 15 minutes ago

--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that its Board of Directors has set the record date, the distribution ratio ...

View the full article

[ImmInst]

BioTime, Inc. Announces Record Date, Distribution Ratio, and Distribution Date ...
Equities.com - 3 hours ago

--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that its Board of Directors has set the record date, the distribution ratio ...

BioTime Inc.: BioTime, Inc. Announces Record Date, Distribution Ratio, and ... - The Wall Street Transcript
BioTime's Board of Directors Makes Decisions About Subsidiary OncoCyte - Investing News Network (press release) (registration) (blog)

View the full article

[ImmInst]

Is BioTime, Inc. (BTX) A Good Stock To Buy?
Insider Monkey (blog) - 2 hours ago

With this in mind, we have decided to take a closer look at the latest hedge fund activity surrounding BioTime, Inc.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 8.99%
News Watch International - 53 minutes ago

BioTime, Inc. (NYSEMKT:BTX) rose 0.27% or 0.01 points on Friday and made its way into the gainers of the day. After trading began at $3.77 the stock was seen hitting $4.1 as a peak level and $3.67 as the lowest level.

View the full article

[ImmInst]

BioTime Inc.: OncoCyte Appoints Dr. Andrew J. Last to Its Board of Directors
The Wall Street Transcript - 12 minutes ago

Dr. Last will also serve on OncoCyte's Audit Committee. previously announced that it plans to be the third member of the (NYSE MKT: BTX) family of companies to begin trading publicly, following BioTime's distribution of common stock to shareholders.

View the full article

[ImmInst]

BioTime Inc.: OncoCyte Appoints Dr. Andrew J. Last to Its Board of Directors
The Wall Street Transcript - 3 hours ago

Dr. Last will also serve on OncoCyte's Audit Committee. previously announced that it plans to be the third member of the (NYSE MKT: BTX) family of companies to begin trading publicly, following BioTime's distribution of common stock to shareholders.

OncoCyte (BTX) Adds Andrew Last as Director - StreetInsider.com

View the full article

[ImmInst]

Oppenheimer Initiates Coverage on BioTime, Inc. (BTX)
Storm Investor - 1 hour ago

BioTime logo Investment analysts at Oppenheimer started coverage on shares of BioTime, Inc. (AMEX:BTX) in a research note issued to investors on Tuesday, AnalystRatings.

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Rally 15.16%
Insider Trading Report - 3 hours ago

Shares of BioTime, Inc. (NYSEMKT:BTX) rose by 15.16% in the past week and 24.78% for the last 4 weeks. In the past week, the shares has outperformed the S&P 500 by 12.06% and the outperformance increases to 26.55% for the last 4 weeks.

View the full article

[ImmInst]

Update: BioTime, Inc. Short Interest Disclosure
Money Flow Index - 46 minutes ago

BioTime, Inc. (NYSEMKT:BTX), A drop of 22,855 shares or 0.3% was seen in the short interest of Biotime Inc. Even as the interest dropped from 7,730,830 shares on November 30,2015 to 7,707,975 shares on December 15,2015, the days to cover came in at ...

View the full article

[ImmInst]

Zacks Short Term Rating on BioTime, Inc.
Insider Trading Report - 1 hour ago

BioTime, Inc. (NYSEMKT:BTX) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 1 by 1 Wall Street Analysts.

View the full article

[ImmInst]

Oppenheimer Starts BioTime, Inc. (BTX) at Outperform
StreetInsider.com - Dec 22, 2015

Oppenheimer initiates coverage on BioTime, Inc. (NYSE: BTX) with a Outperform rating and a price target of $10.00. Analyst Ling Wang commented, "We are initiating coverage of Biotime, Inc. (BTX) with an Outperform rating and 12-18-month price target of ...

View the full article

[ImmInst]

BioTime, Inc. (NYSEMKT:BTX) is presenting at the 2015 World Stem Cell Summit ...
Inside Trade - 4 hours ago

BioTime, Inc. (NYSEMKT:BTX) announced that its co-Chief Executive Officer Michael D. West, PhD will deliver a keynote presentation at the 2015 World Stem Cell Summit in Atlanta, Georgia on Saturday, December 12, 2015 from 11:30am to 12:30pm EST.

View the full article

[ImmInst]

BioTime, Inc. (NYSEMKT:BTX) is presenting at the 2015 World Stem Cell Summit ...
Inside Trade - 14 hours ago

BioTime, Inc. (NYSEMKT:BTX) announced that its co-Chief Executive Officer Michael D. West, PhD will deliver a keynote presentation at the 2015 World Stem Cell Summit in Atlanta, Georgia on Saturday, December 12, 2015 from 11:30am to 12:30pm EST.

View the full article

[ImmInst]

Adjustments Affecting BioTime, Inc. Common Share Purchase Warrants Expiring ...
Business Wire (press release) - 1 hour ago

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX) announced today that pursuant to Section 6.1© of the Warrant Agreement dated as of October 1, 2013, as amended September 19, 2014, between BioTime and American ...

View the full article

[ImmInst]

Why Biotime Inc Just Disclosed Huge New Oncocyte Corp Stake
OctaFinance.com - 13 hours ago

Per Biotime Inc's filing, the filler now owns 58.55% of the company, holding 14,866,888 shares. Oncocyte Corp is a newly disclosed equity position and the filing was required due to activity on December 30, 2015.

View the full article

[ImmInst]

BioTime Inc (BTX) Drops 8.02% on January 19
Equities.com - 2 hours ago

BioTime Inc (BTX) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 8.02% to $2.41, a loss of $-0.21 per share.

View the full article

[ImmInst]

Broadwood Partners Lp Purchases 300000 Shares of BioTime, Inc. (BTX) Stock
Corvus Business Newswire - 1 hour ago

BioTime logo BioTime, Inc. (NYSEMKT:BTX) Director Broadwood Partners Lp purchased 300,000 shares of the business's stock in a transaction on Wednesday, January 20th.

View the full article

[ImmInst]

BioTime, Inc. (BTX) Director Purchases $705000.00 in Stock
EMQ - 3 hours ago

BioTime logo BioTime, Inc. (NYSEMKT:BTX) Director Broadwood Partners Lp bought 300,000 shares of the stock in a transaction that occurred on Wednesday, January 20th.

View the full article

[ImmInst]

Hot News: ConnectOne Bancorp, Inc. (NASDAQ:CNOB), BioTime, Inc. (NYSEMKT:BTX ...
Stock Transcript - 2 hours ago

ConnectOne Bancorp, Inc. (NASDAQ:CNOB) announced results for the fourth quarter ended December 31, 2015, the sixth full quarter following the Merger between the Company and legacy ConnectOne completed on July 1, 2014 (the “Merger”).

View the full article

[ImmInst]

Company Shares of BioTime, Inc. (NYSEMKT:BTX) Drops by -5.84%
Bull Report - 19 minutes ago

BioTime, Inc. (NYSEMKT:BTX) has lost 5.84% during the past week and dropped 40.98% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 7.45%.

View the full article